Pharma Predicts Modest Tariff Impact, Depending On What Comes Next

 
• By Jessica Merrill
  
Pharma companies hope promises for more domestic investment could spare them from sector-specific tariffs. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Market Access